Skip to main content
Top
Published in: Gastric Cancer 5/2018

Open Access 01-09-2018 | Technical Note

Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS)

Authors: Zhining Liu, Weidong Ren, Jintao Guo, Ying Zhao, Siyu Sun, Yuhong Li, Zhijun Liu

Published in: Gastric Cancer | Issue 5/2018

Login to get access

Abstract

Objective

Transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent (TUS-OCCA) has recently been suggested as a valuable mass-screening tool for gastric cancer. The aim of this study was to propose a producible stomach ultrasound reporting and data system (Su-RADS) using TUS-OCCA for gastric cancer screening.

Patients

The study includes information of 2738 patients who underwent both gastroscopy and TUS-OCCA examinations recorded in software system. Gastroscopy examination with pathological diagnosis was considered as gold standard. Various gastric lesions were classified into category 1–5 based on gastric wall thicknesses of them (especially the mucosa layer).

Results

The total malignant ratios of patients enrolled in this study were 17.1% (469/2738). The malignant ratios for category 1–5 were, respectively, 1.1, 1.7, 12.2, 34.2 and 78.1%. Category 2 indicated mild thickening of gastric wall at low risk for malignancy (1.7%); category 3 indicated moderate thickening at moderate risk for malignancy (12.2%); category 4 indicated severe thickening at high risk for malignancy (34.2%); category 5 indicated extremely severe thickening at extremely high risk for malignancy (78.1%). If category 2 was identified as cut-off point distinguishing between benign and malignant, the sensitivity and specificity by Su-RADS are 95.1 and 78.6%, respectively.

Conclusion

The Su-RADS system could inform the physicians about key findings, indicating the risk for malignancy and necessity of additional gastroscopy examination. Prospectively randomly controlled study design with larger clinical trial is needed for further investigations.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29(6):895–905.CrossRefPubMed Sugano K. Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 2015;29(6):895–905.CrossRefPubMed
2.
go back to reference Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.CrossRefPubMed Leung WK, Wu MS, Kakugawa Y, Kim JJ, Yeoh KG, Goh KL, et al. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol. 2008;9(3):279–87.CrossRefPubMed
3.
go back to reference Nakajima S. Gastric cancer screening in Japan, now and tomorrow. Nihon Rinsho. 2012;70:1686–93.PubMed Nakajima S. Gastric cancer screening in Japan, now and tomorrow. Nihon Rinsho. 2012;70:1686–93.PubMed
4.
go back to reference Genta RM. Screening for gastric cancer: does it make sense? Aliment Pharmacol Ther. 2004;20(Suppl 2):42–7.CrossRefPubMed Genta RM. Screening for gastric cancer: does it make sense? Aliment Pharmacol Ther. 2004;20(Suppl 2):42–7.CrossRefPubMed
5.
go back to reference Hamashima C. Current issues and future perspectives of gastric cancer screening. World J Gastroenterol. 2014;20:13767e74.CrossRef Hamashima C. Current issues and future perspectives of gastric cancer screening. World J Gastroenterol. 2014;20:13767e74.CrossRef
6.
go back to reference Menon S, Ttudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis. Endosc Int Open. 2014;02:E46e50. Menon S, Ttudgill N. How commonly is upper gastrointestinal cancer missed at endoscopy? A meta-analysis. Endosc Int Open. 2014;02:E46e50.
7.
go back to reference Choi KS, Jun JK, Park EC, Park S, Jung KW, Han MA, Choi IJ, Lee HY. Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One. 2012;7(11):e50041.CrossRefPubMedPubMedCentral Choi KS, Jun JK, Park EC, Park S, Jung KW, Han MA, Choi IJ, Lee HY. Performance of different gastric cancer screening methods in Korea: a population-based study. PLoS One. 2012;7(11):e50041.CrossRefPubMedPubMedCentral
9.
go back to reference Liu Z, Guo J, Li J, Wang S, Tang S, Xie L, et al. Gastric lesions: demonstrated by transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent. Ultraschall Med. 2016;37(4):405–11.PubMed Liu Z, Guo J, Li J, Wang S, Tang S, Xie L, et al. Gastric lesions: demonstrated by transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent. Ultraschall Med. 2016;37(4):405–11.PubMed
10.
12.
go back to reference Liu Z, Guo J, Sun S, Ren W, Tang S, Xie L, et al. Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for demonstrating small gastric subepithelial masses. Abdom Imaging. 2014;39(2):424–31.CrossRefPubMed Liu Z, Guo J, Sun S, Ren W, Tang S, Xie L, et al. Evaluation of transabdominal ultrasound after oral administration of an echoic cellulose-based gastric ultrasound contrast agent for demonstrating small gastric subepithelial masses. Abdom Imaging. 2014;39(2):424–31.CrossRefPubMed
13.
go back to reference Liu Z, Guo J, Ren W, Sun S, Tang S, Xie L. A gastric calcifying fibrous pseudotumor detected by transabdominal ultrasound after oral administration of an echoic cellulose-based gastrointestinal ultrasound contrast agent. Ultraschall Med. 2014;35(2):181–3.PubMed Liu Z, Guo J, Ren W, Sun S, Tang S, Xie L. A gastric calcifying fibrous pseudotumor detected by transabdominal ultrasound after oral administration of an echoic cellulose-based gastrointestinal ultrasound contrast agent. Ultraschall Med. 2014;35(2):181–3.PubMed
14.
go back to reference Li S, Huang P, Wang Z, Chen J, Xu H, Wang L, et al. Preoperative T staging of advanced gastric cancer using double contrast-enhanced ultrasound. Ultraschall Med. 2012;33:E218–24.CrossRefPubMed Li S, Huang P, Wang Z, Chen J, Xu H, Wang L, et al. Preoperative T staging of advanced gastric cancer using double contrast-enhanced ultrasound. Ultraschall Med. 2012;33:E218–24.CrossRefPubMed
15.
go back to reference Shi H, Yu XH, Guo XZ, Guo Y, Zhang H, Qian B, et al. Double contrast-enhanced two-dimensional and three-dimensional ultrasonography for evaluation of gastric lesions. World J Gastroenterol. 2012;18(31):4136–44.CrossRefPubMedPubMedCentral Shi H, Yu XH, Guo XZ, Guo Y, Zhang H, Qian B, et al. Double contrast-enhanced two-dimensional and three-dimensional ultrasonography for evaluation of gastric lesions. World J Gastroenterol. 2012;18(31):4136–44.CrossRefPubMedPubMedCentral
16.
go back to reference Hamashima C, Okamoto M, Shabana M, Osaki Y, Kishimoto T. Sensitivity of endoscopic screening for gastric cancer by the incidence method. Int J Cancer. 2013;133:653–9.CrossRefPubMed Hamashima C, Okamoto M, Shabana M, Osaki Y, Kishimoto T. Sensitivity of endoscopic screening for gastric cancer by the incidence method. Int J Cancer. 2013;133:653–9.CrossRefPubMed
18.
go back to reference Yamamichi N, Hirano C, Ichinose M, Takahashi Y, Minatsuki C, Matsuda R, et al. Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation. Gastric Cancer. 2016;19(3):1016–22. https://doi.org/10.1007/s10120-015-0558-0 (Epub 2015 Oct 20).CrossRefPubMed Yamamichi N, Hirano C, Ichinose M, Takahashi Y, Minatsuki C, Matsuda R, et al. Atrophic gastritis and enlarged gastric folds diagnosed by double-contrast upper gastrointestinal barium X-ray radiography are useful to predict future gastric cancer development based on the 3-year prospective observation. Gastric Cancer. 2016;19(3):1016–22. https://​doi.​org/​10.​1007/​s10120-015-0558-0 (Epub 2015 Oct 20).CrossRefPubMed
19.
go back to reference Yamamichi N, Hirano C, Takahashi Y, Minatsuki C, Nakayama C, Matsuda R, et al. Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis. Gastric Cancer. 2016;19(2):670–5. https://doi.org/10.1007/s10120-015-0515-y (Epub 2015 Jul 30).CrossRefPubMed Yamamichi N, Hirano C, Takahashi Y, Minatsuki C, Nakayama C, Matsuda R, et al. Comparative analysis of upper gastrointestinal endoscopy, double-contrast upper gastrointestinal barium X-ray radiography, and the titer of serum anti-Helicobacter pylori IgG focusing on the diagnosis of atrophic gastritis. Gastric Cancer. 2016;19(2):670–5. https://​doi.​org/​10.​1007/​s10120-015-0515-y (Epub 2015 Jul 30).CrossRefPubMed
20.
go back to reference Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104(6):1524–32.CrossRefPubMed Carmack SW, Genta RM, Schuler CM, Saboorian MH. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104(6):1524–32.CrossRefPubMed
21.
go back to reference Takeuchi C, Yamamichi N, Shimamoto T, Takahashi Y, Mitsushima T, Koike K. Gastric polyps diagnosed by double-contrast upper gastrointestinal barium X-ray radiography mostly arise from the Helicobacter pylori-negative stomach with low risk of gastric cancer in Japan. Gastric Cancer. 2017;20(2):314–21. https://doi.org/10.1007/s10120-016-0607-3 (Epub 2016 Mar 14).CrossRefPubMed Takeuchi C, Yamamichi N, Shimamoto T, Takahashi Y, Mitsushima T, Koike K. Gastric polyps diagnosed by double-contrast upper gastrointestinal barium X-ray radiography mostly arise from the Helicobacter pylori-negative stomach with low risk of gastric cancer in Japan. Gastric Cancer. 2017;20(2):314–21. https://​doi.​org/​10.​1007/​s10120-016-0607-3 (Epub 2016 Mar 14).CrossRefPubMed
22.
go back to reference Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44(1):74–94.CrossRefPubMed Dinis-Ribeiro M, Areia M, de Vries AC, Marcos-Pinto R, Monteiro-Soares M, O’Connor A, et al. Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy. 2012;44(1):74–94.CrossRefPubMed
23.
go back to reference Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, Standards of Practice Committee, American Society for Gastrointestinal Endoscopy, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.CrossRefPubMed Hirota WK, Zuckerman MJ, Adler DG, Davila RE, Egan J, Leighton JA, Standards of Practice Committee, American Society for Gastrointestinal Endoscopy, et al. ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc. 2006;63(4):570–80.CrossRefPubMed
24.
go back to reference ASGE Standards of Practice Committee, Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78(2):216–24.CrossRef ASGE Standards of Practice Committee, Sharaf RN, Shergill AK, Odze RD, Krinsky ML, Fukami N, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc. 2013;78(2):216–24.CrossRef
25.
go back to reference Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco FH. Pylori infection and gastric cancer: state of the art (review). Int J Oncol. 2013;42(1):5–18.CrossRefPubMed Conteduca V, Sansonno D, Lauletta G, Russi S, Ingravallo G, Dammacco FH. Pylori infection and gastric cancer: state of the art (review). Int J Oncol. 2013;42(1):5–18.CrossRefPubMed
28.
go back to reference Cui R, Zhou L. Helicobacter pylori infection: an overview in 2013, focus on therapy. Chin Med J (Engl). 2014;127(3):568–73. Cui R, Zhou L. Helicobacter pylori infection: an overview in 2013, focus on therapy. Chin Med J (Engl). 2014;127(3):568–73.
29.
go back to reference O’Connor A, Gisbert JP, McNamara D, O’Morain C. Treatment of Helicobacter pylori infection 2010. Helicobacter. 2010;15(Suppl 1):46–52.CrossRefPubMed O’Connor A, Gisbert JP, McNamara D, O’Morain C. Treatment of Helicobacter pylori infection 2010. Helicobacter. 2010;15(Suppl 1):46–52.CrossRefPubMed
31.
go back to reference Eusebi LH, Ceroni L, Laterza L, Kurelac I, Fuccio L. The association between Helicobacter pylori and gastric cancer: the role of infection’s eradication. Recent Adv Recenti Prog Med. 2010;101(2):66–9. Eusebi LH, Ceroni L, Laterza L, Kurelac I, Fuccio L. The association between Helicobacter pylori and gastric cancer: the role of infection’s eradication. Recent Adv Recenti Prog Med. 2010;101(2):66–9.
32.
go back to reference Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, Jung HC, Song IS. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16(5):382–8.CrossRefPubMed Yoon H, Kim N, Lee HS, Shin CM, Park YS, Lee DH, Jung HC, Song IS. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter. 2011;16(5):382–8.CrossRefPubMed
33.
go back to reference Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007). Gastric Cancer. 2017. https://doi.org/10.1007/s10120-017-0716-7 (Epub ahead of print).CrossRefPubMed Katai H, Ishikawa T, Akazawa K, Isobe Y, Miyashiro I, Oda I, et al. Five-year survival analysis of surgically resected gastric cancer cases in Japan: a retrospective analysis of more than 100,000 patients from the nationwide registry of the Japanese Gastric Cancer Association (2001-2007). Gastric Cancer. 2017. https://​doi.​org/​10.​1007/​s10120-017-0716-7 (Epub ahead of print).CrossRefPubMed
Metadata
Title
Preliminary opinion on assessment categories of stomach ultrasound report and data system (Su-RADS)
Authors
Zhining Liu
Weidong Ren
Jintao Guo
Ying Zhao
Siyu Sun
Yuhong Li
Zhijun Liu
Publication date
01-09-2018
Publisher
Springer Japan
Published in
Gastric Cancer / Issue 5/2018
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-018-0798-x

Other articles of this Issue 5/2018

Gastric Cancer 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.